IL10 and diabetes mellitus: However, recent studies have shown that rather than promoting disease, cross-reactivity can suppress auto-immunity through regulatory function of HSP-reactive T-cells and IL-10 production [29], [30] as seen in case of adjuvant-induced arthritis [31] and diabetes [32] after HSP vaccination in animal models.